Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Maitake sales volume increased despite a decline in the average selling price, while both sales volume and average selling prices for king oyster mushrooms and buna-shimeji mushrooms increased. Sales of other mushrooms, health foods and culture-medium activators also increased.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥10,202 million (YoY +15.4%) |
| Operating profit | ¥-433 million |
| Ordinary income | ¥-471 million |
| Profit attributable to owners of the parent | ¥-306 million |
| Net income per share | -¥7.70 |
| Equity ratio | End of the current fiscal period 38.9 / End of previous period 39.2 |
| Total assets | ¥35,286 million |
| Net assets | ¥13,713 million |
| Cash flows from operating activities | ¥-625 million |
| Cash flows from investing activities | ¥-428 million |
| Cash flows from financing activities | ¥-940 million |
| Cash and cash equivalents at end of period | ¥1,976 million |
| Full-year earnings forecast | Net Sales ¥56,910 million (YoY +6.5%) / Operating profit ¥4,140 million (YoY -4.1%) / Ordinary income ¥3,950 million (YoY -5.8%) / Net income ¥2,540 million (YoY -14.1%) |
| Revision to Earnings Forecast | No |
| Annual Dividend Forecast | ¥23 → ¥20（-13.0%） |
| Segment revenue | Mushroom business ¥7,873 million (YoY +9.2%), Other (outside reportable segments) ¥110 million (YoY +48.5%) |
| Segment profit | Mushroom business ¥-420 million, Other (outside reportable segments) ¥-14 million |
| Depreciation and amortization | ¥587 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 39,910,700 |
| Treasury Shares at Period-End | 27,878 |
| Factors Behind Changes in Business Performance | Maitake sales volume increased despite a decline in the average selling price, while both sales volume and average selling prices for king oyster mushrooms and buna-shimeji mushrooms increased. Sales of other mushrooms, health foods and culture-medium activators also increased. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Although the average selling price of maitake mushrooms was below the year-earlier level, sales volume increased. Both sales volume and average selling prices for king oyster mushrooms and buna-shimeji mushrooms increased. Sales of other mushrooms, health foods and culture-medium activators also increased.